×
0 0 0 0 0 0.000852151682999556 -0.00149126544524926 -0.0264167021729868
Stockreport

Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions

Immunomedics, Inc (IMMU)  More Company Research Source: GlobeNewswire
Last immunomedics, inc earnings: 11/7 04:05 pm Check Earnings Report
PDF Clinical Collaboration with Yale University to Evaluate Sacituzumab Govitecan in Two Phase 2 Studies in Endometrial and Cervical Cancers Research Collaborations with Yale University, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Research Center to Further Investigate Sacituzumab Govitecan and Labetuzumab Govitecan in Preclinical Cancer Models MORRIS PLAINS, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced a collaboration with the Yale Cancer Center at the Yale University School of Medicine to evaluate Immunomedics’ lead ADC product candidate, sacituzumab govitecan, as a single agent in two Phase 2 studies in patients with persistent or recurrent endometrial and cervical cancers. “The treatment of advanced/metastatic endometrial and cervical cancers is challenging and therapeutic options for these patien [Read more]

IMPACT SNAPSHOT EVENT TIME: IMMU
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
IMMU alerts

from News Quantified
Opt-in for
IMMU alerts

from News Quantified